MTPOF yields 2.30% · JNJ yields 2.13%● Live data
📍 MTPOF pulled ahead of the other in Year 1
Combined, MTPOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MTPOF + JNJ for your $10,000?
Metropolitan Bank & Trust Company, together with its subsidiaries, provides various commercial and investment banking products and services in the Philippines, rest of Asia, the United States, and Europe. The company's Consumer Banking segment offers consumer type loans and support for the sourcing and generation of consumer business. Its Corporate Banking segment engages in handling loans and other credit facilities; and provides deposit and current accounts for corporate and institutional customers. The company's Investment Banking segment offers structured financing; services relating to privatizations, initial public offerings, and mergers and acquisitions; and advisory services to individuals and institutions. Its Treasury segment provides money market, trading, and treasury services. The company's Branch Banking segment handles branch deposits, as well as offers loans and other loan related products for middle market clients. Its Others segment provides remittances, leasing, account financing, and other support services. The company also provides trade finance, thrift banking, foreign fund transfer, foreign exchange, online and mobile banking, collateral, and trust services. It operates through a network of 701 branches and 1,770 automated teller machines. The company was incorporated in 1962 and is headquartered in Makati City, the Philippines.
Full MTPOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.